The new 2018 ACC/AHA Guideline on the Management of Blood Cholesterol allows for more personalized care for patients compared to its 2013 predecessor. Among the biggest changes: more detailed risk assessments and new cholesterol-lowering drug options for people at the highest risk for cardiovascular disease. The guidelines were released Nov. 10 at AHA 2018 in Chicago, IL, and simultaneously published in the Journal of the American College of Cardiology and Circulation.
↧